BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20872188)

  • 1. Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.
    Yamaguchi I; Kidoya E; Suzuki M; Kimura H
    Radiol Phys Technol; 2011 Jan; 4(1):43-52. PubMed ID: 20872188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-arterial and portal-venous phase imaging of the liver with a multislice CT scanner in patients without circulatory disturbances: automatic bolus tracking or empirical scan delay?
    Itoh S; Ikeda M; Achiwa M; Satake H; Iwano S; Ishigaki T
    Eur Radiol; 2004 Sep; 14(9):1665-73. PubMed ID: 15067427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hypervascular hepatocellular carcinoma revealed by double arterial phase CT performed with single breath-hold scanning and automatic bolus tracking.
    Kim T; Murakami T; Hori M; Takamura M; Takahashi S; Okada A; Kawata S; Cruz M; Federle MP; Nakamura H
    AJR Am J Roentgenol; 2002 Apr; 178(4):899-904. PubMed ID: 11906869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
    Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
    J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
    Tozaki M; Naruo K; Fukuda K
    Radiat Med; 2005 Dec; 23(8):533-8. PubMed ID: 16555560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter trial for optimization of bolus tracking settings and contrast material injection protocol in arterial dominant phase of dynamic computed tomography for diagnosis of hepatocellular carcinoma].
    Yoshikawa S; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Ichikawa T; Hayakawa A; Shiosakai K; Awai K; Yoshimitsu K; Yamashita Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Aug; 70(8):805-13. PubMed ID: 25142392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinomas: correlation between time to peak hepatocellular carcinomas enhancement and time to peak aortic enhancement.
    Sun X; Liu C; Liang C; Sun C; Liu S; Deng K
    Comput Med Imaging Graph; 2009 Jun; 33(4):312-6. PubMed ID: 19303253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized scan delay for late hepatic arterial or pancreatic parenchymal phase in dynamic contrast-enhanced computed tomography with bolus-tracking method.
    Noda Y; Kawai N; Ishihara T; Tsuboi Y; Kaga T; Miyoshi T; Hyodo F; Matsuo M
    Br J Radiol; 2021 Jun; 94(1122):20210315. PubMed ID: 33956484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
    Hori M; Murakami T; Oi H; Kim T; Takahashi S; Matsushita M; Tomoda K; Narumi Y; Kadowaki K; Nakamura H
    Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.